GLA
DCPH

Great Lakes Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Great Lakes Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-83,327
Closed -$3.43M – 616
2020
Q1 		$3.43M Buy
+83,327
New +$4.63M 0.1% 222

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Great Lakes Advisors's DCPH Position: Q2 2020 in Review

Great Lakes Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2020, closing a stake of 83,327 shares — an estimated $3.43M sold.

Great Lakes Advisors first reported a position in DCPH in Q1 2020 and held it in 1 quarter. The position peaked at $3.43M in Q1 2020. 168 funds tracked by Wall St. Rank hold DCPH as of Q2 2020.

  • Great Lakes Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Great Lakes Advisors sold 83,327 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $3.43M.
  • Great Lakes Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Great Lakes Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.43M in Q1 2020.
  • 168 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Great Lakes Advisors's 13F filing for Q2 2020, filed 7 Aug 2020.